Patent · US Active

Modulating the alternative complement pathway

US11407820B2 · kind B2 · utility

0Cited by
7References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 21, 2018
Grant dateAug 9, 2022
Priority date—
Expiry dateDec 3, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y402/01002
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compositions, including pharmaceutical compositions, and methods for modulating, i.e., stimulating or inhibiting, activity of the alternative complement pathway, and methods of identifying factor H-binding proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.